In this Issue:
Deferred therapy improves OS in newly diagnosed MCL
Intensified chemo and alloHSCT for elderly ALL
Outcomes in follicular lymphoma with histologic transformation after immunochemotherapy
No benefit of GnRHa in preserving ovarian function and fertility after chemo
Impact of donor EBV serostatus on the incidence of GVHD
Bendamustine + rituximab vs fludarabine, cyclophosphamide and rituximab in advanced CLL
Poor outcomes after progression on brentuximab vedotin in classical Hodgkin lymphoma
Panobinostat with or without rituximab in relapsed DLBCL
Front-line idelalisib in CLL causes immune-mediated hepatotoxicity
High EFS with minimum-dose anthracycline in childhood APL
Please login below to download this issue (PDF)